Status:
TERMINATED
Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram
Lead Sponsor:
Madigan Army Medical Center
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted t...
Detailed Description
Describe step-by-step how the study will be conducted from beginning to end 1. After IRB approval, the research pharmacist will provide motrin and ketorolac in identical packets labeled 1-88, after r...
Eligibility Criteria
Inclusion
- English speaking
- premenopausal females age 18-45
- patients currently undergoing HSG as part of routine work-up for infertility or subfertility, - - patients with negative urine pregnancy test within 24 hours of the scheduled procedure
- patients having performance of HCG between menstrual cycle days 5-12n
Exclusion
- Non-English speaking
- patients with history of previous HSG performed
- patients with contrast allergy or other contraindications to HSG
- patients with contraindications to NSAID use
- Patients with the following:
- unwilling to consent
- positive urine pregnancy test within 24 hours of the scheduled procedure
- active renal or hepatic disease
- chronic narcotic users
- use of pain medications within 12 hours of the scheduled procedure
- patients with chronic pain conditions (fibromyalgia, complex regional pain syndrome, etc.)
- patients with unknown uterine anatomical pathology
Key Trial Info
Start Date :
March 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05190341
Start Date
March 24 2022
End Date
October 10 2024
Last Update
December 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madigan Army Medical Center
Tacoma, Washington, United States, 98431